Compare M&T Bank Corporation (MTB) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Twist Bioscience Corp — how do they compare? M&T Bank Corporation trades at $217.33 (market cap $31.42B), while Twist Bioscience Corp trades at $159.64 (market cap $10.08B). The key difference: M&T Bank Corporation is far larger — about 3.1× Twist Bioscience Corp's market cap, and M&T Bank Corporation pays a 2.76% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold M&T Bank Corporation for 100 Days and Twist Bioscience Corp for 27 Days on average.
| MTB | TWST | |
|---|---|---|
Market Cap | $31.42B | $10.08B |
Volume | 1,438,219 | 4,229,037 |
Sector | Financials | Health |
52-Week High | $254.09 | $205.00 |
52-Week Low | $178.63 | $25.45 |
Typical Hold Time | 100 Days | 27 Days |
Enterprise Value | $47.77B | $10.01B |
Dividend Yield | 2.76% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
M&T Bank Corporation (MTB) trades at $217.23, up 0.29% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with P/E of 11.52, net margin of 30.85%, and consistent dividend payments. Recent news highlights branch expansion and AI investments driving loan growth, while analyst consensus remains cautiously optimistic with a $258.92 price target.
MTB presents a compelling value opportunity with attractive valuation metrics and solid profitability, though technical indicators suggest near-term pressure. The bank's strategic investments in technology and expanding fee businesses support long-term growth, but investors should monitor interest rate sensitivity and competitive banking sector dynamics.
Twist Bioscience (TWST) trades at $162.43, up 4.36% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical signal with RSI at 29.02 indicating potential oversold conditions. Fundamentally, revenue growth continues (2025: $377M, 2026: $432M projected) but profitability remains elusive with negative margins. Recent partnership with Eli Lilly's TuneLab platform highlights strategic positioning in AI-driven drug discovery.
While analyst consensus favors Buy (73%), the stock trades above the $145.20 target, suggesting limited near-term upside. Key risks include persistent cash burn (-$44M net CF in 2025) and high valuation multiples (P/S: 21.5). The AI biotech partnership provides growth catalyst potential, but profitability timeline remains uncertain for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
